Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco M Muggia

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The Oncologist|March 30, 2004
The emerging roles of screening and prevention in women's cancerFranco M Muggia
Seminars in Oncology|January 16, 2007
New and emerging intraperitoneal (IP) drugs for ovarian cancer treatmentFranco M Muggia
Cancer Investigation|May 15, 2003
Treatment of sarcomas: thinking out-of-the-boxFranco M Muggia, Anna Pavlick
Journal of the National Cancer Institute|May 4, 2006
Completion rates of adjuvant chemotherapy for colon cancer: a historical perspectiveVictor R Grann, Franco M Muggia
Cancer|April 1, 2018
Testicular Cancer: Risk Factors and the Role of Adjuvant ChemotherapyEdwin M Jacobs, Franco M Muggia
Oncology (Williston Park, N.Y.)|August 29, 2018
Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer PointsLeslie R Boyd, Franco M Muggia
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2014
The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancerTamar Safra, Ori Rogowski, Franco M Muggia
Journal of Neuro-Oncology|August 8, 2002
Endometrial carcinoma with cerebellar metastasis: a case report and review of the literatureSanjeev Sewak, Franco M Muggia, David Zagzag
Oncology (Williston Park, N.Y.)|November 27, 2012
Targeted therapy: its status and promise in selected solid tumors part I: areas of major impactJennifer Wu, Sasha O Joseph, Franco M Muggia
Oncology (Williston Park, N.Y.)|January 22, 2013
Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integrationSasha O Joseph, Jennifer Wu, Franco M Muggia
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Oncologist|March 30, 2004
The emerging roles of screening and prevention in women's cancerFranco M Muggia
Seminars in Oncology|January 16, 2007
New and emerging intraperitoneal (IP) drugs for ovarian cancer treatmentFranco M Muggia
Cancer Investigation|May 15, 2003
Treatment of sarcomas: thinking out-of-the-boxFranco M Muggia, Anna Pavlick
Journal of the National Cancer Institute|May 4, 2006
Completion rates of adjuvant chemotherapy for colon cancer: a historical perspectiveVictor R Grann, Franco M Muggia
Cancer|April 1, 2018
Testicular Cancer: Risk Factors and the Role of Adjuvant ChemotherapyEdwin M Jacobs, Franco M Muggia
Oncology (Williston Park, N.Y.)|August 29, 2018
Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer PointsLeslie R Boyd, Franco M Muggia
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2014
The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancerTamar Safra, Ori Rogowski, Franco M Muggia
Journal of Neuro-Oncology|August 8, 2002
Endometrial carcinoma with cerebellar metastasis: a case report and review of the literatureSanjeev Sewak, Franco M Muggia, David Zagzag
Oncology (Williston Park, N.Y.)|November 27, 2012
Targeted therapy: its status and promise in selected solid tumors part I: areas of major impactJennifer Wu, Sasha O Joseph, Franco M Muggia
Oncology (Williston Park, N.Y.)|January 22, 2013
Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integrationSasha O Joseph, Jennifer Wu, Franco M Muggia
Pageof 6